Onesource Specialty Pharma Limited — Important, 09-04-2025: General Updates

OneSource Specialty Pharma Limited has secured GMP certification from ANVISA, Brazil's health regulatory agency, for its flagship Unit 2 facility following a successful inspection. This approval enhances OneSource’s capabilities to operate within the Brazilian market, unlocking growth opportunities in the local pharmaceutical sector. The certification reflects the company's commitment to adhering to international quality and safety standards, potentially improving its competitiveness and market position. Investors should view this development positively, as it may lead to expanded sales and revenue growth in the region, indicating a promising outlook for future performance.